Wang Ping, Huang Xiaomei, Jiang Chenyuan, Yang Rushuang, Wu Jialing, Liu Yinghui, Feng Shuangshuang, Wang Tingting
Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Research Center, Health Science Center, Ningbo University, Ningbo, 315211, Zhejiang, China.
Department of Marine Biology, Xiamen Ocean Vocational College, Xiamen, 361100, Fujian, China.
Arch Pharm Res. 2024 Jun;47(6):505-537. doi: 10.1007/s12272-024-01500-6. Epub 2024 Jun 8.
The oceans are rich in diverse microorganisms, animals, and plants. This vast biological complexity is a major source of unique secondary metabolites. In particular, marine fungi are a promising source of compounds with unique structures and potent antibacterial properties. Over the last decade, substantial progress has been made to identify these valuable antibacterial agents. This review summarizes the chemical structures and antibacterial activities of 223 compounds identified between 2012 and 2023. These compounds, effective against various bacteria including drug-resistant strains such as methicillin-resistant Staphylococcus aureus, exhibit strong potential as antibacterial therapeutics. The review also highlights the relevant challenges in transitioning from drug discovery to product commercialization. Emerging technologies such as metagenomics and synthetic biology are proposed as viable solutions. This paper sets the stage for further research on antibacterial compounds derived from marine fungi and advocates a multidisciplinary approach to combat drug-resistant bacteria.
海洋中富含各种微生物、动物和植物。这种巨大的生物复杂性是独特次生代谢产物的主要来源。特别是,海洋真菌是具有独特结构和强大抗菌特性的化合物的一个有前景的来源。在过去十年中,在鉴定这些有价值的抗菌剂方面取得了重大进展。本综述总结了2012年至2023年间鉴定出的223种化合物的化学结构和抗菌活性。这些化合物对包括耐甲氧西林金黄色葡萄球菌等耐药菌株在内的各种细菌有效,展现出作为抗菌治疗药物的强大潜力。该综述还强调了从药物发现到产品商业化过程中的相关挑战。宏基因组学和合成生物学等新兴技术被提议作为可行的解决方案。本文为进一步研究海洋真菌衍生的抗菌化合物奠定了基础,并倡导采用多学科方法来对抗耐药细菌。